Cover Image

Retrospective analysis of clinical profile, prognostic factors and outcomes of patients with emphysematous pyelonephritis

Sasikumar S .

Abstract


Aim: To study the clinical profile, prognostic factors

and outcome in patients with emphysematous

pyelonephritis (EPN). Methods: All patients admitted with

a diagnosis of EPN between the period from March 2014

to March 2017 were included in this retrospective study.

Results: Overall 64 cases were included in this study out

of which 49 were females, 15 were males. 43 (67.2%)

cases had type 2 Diabetes Mellitus. E.coli (64.1%) was the

commonest microorganism isolated in blood, urine and pus

culture. Presence of shock, DIC, increased serum

creatinine at the time of admission were identified as poor

prognostic factors. Severe hypoalbuminemia, need for

emergency dialysis and presence of polymicrobial infection

were significantly associated with failure of conservative

treatment. Conclusion: EPN requires special attention

because of its life threatening complications mainly due to

sepsis at the initial presentation, and outcome depends

upon the clinical course and prognostic factors.

 


Full Text:

PDF

References


Ahlering TE, Boyd SD, Hamilton CL, Bragin SD,

Chandrasoma PT, Lieskovsky G, Skinner DG.

Emphysematous pyelonephritis: a 5-year experience with

patients. J Urol 1985, 134:1086–1088.

Ambar K, Ankur G, Devendara SR, Ashwini G, Anil B,

Dinesh K. Retrospective analysis of clinical profile and

prognostic factors of 19 patients of emphysematous

pyelonephritis. IntUrolNephrol 2009; 41: 959-966.

Basher AL, Manzoor AB, Mir IB, Mohd AG, Shahnaz AM,

Riyaz AD. Conservative management of emphysematous

pyelonephritis. Ind J EndocrinolMetab 2012; 16: 303-305.

Hildebrand TS, Nibbe L, Frei U, Schindler R. Bilateral

emphysematous pyelonephritis caused by Candida infection.

Am J Kidney Dis 1999; 33: 10-15.

Huang JJ, Tseng CC. Emphysematous pyelonephritis:

clinical radiological classification, management, prognosis

and pathogenesis. Arch Intern Med 2000; 60: 797-805.

James HLT, Chun KC, Ringo WHC, Inchak L, Chi-Kwan K,

Pak-Ling L, Fu-Keung C, Mong KY. Emphysematous

pyelonephritis: an 8 year retrospective review across four

acute hospitals. As J Surg 2013; 36: 121-125.

Kobayashi N, Yoshida K, Kamata S, Uchijima Y, Saitoh H.

A case of emphysematous pyelonephritis with disseminated

intravascular coagulation. Hinyokika Kiyo 1992; 38: 61-66.

Leons J, Humad SM, Sara YA. Emphysematous

pyelonephritis: Case report. Kuwait Med J 2004; 36: 134-136.

Matsuura H, Nakamura T, Inoue T, Yoshikawa K,

Hinoshita F. Case of emphysematous pyelonephritis with

sepsis and disseminated intravascular coagulation. Nihon

JinzoGakkai Shi 2008; 50: 140-146.

Ramachandran A, Snehalatha C, Kapur A. High

prevalence of diabetes and impaired glucose tolerance in

India: National Urban Diabetes Survey. Diabetologia 2001;

: 1094-1101.

Stapleton A. Urinary tract infections in patients with

diabetes. Am J Med 2002, 113:80–84.

Tseng CC, Wu JJ, Wang MC, Hor LI, Ko YH, HuangJJ.

Host and bacterial virulence factors predisposing to

emphysematous pyelonephritis. Am J Kidney Dis 2005;

: 432-439.

Soo Park B, Lee SJ, Wha Kim Y, Sik Huh J, Il Kim J,

Chang SG. Outcome of nephrectomy and kidney-preserving

procedures for the treatment of emphysematous

pyelonephritis. Scand J Urol Nephrol 2006, 40:332–338.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University